Oxidative stress-related gene polymorphism and the risk of preeclampsia

被引:35
作者
Kim, YJ
Park, HS
Park, MH
Suh, SH
Pang, MG
机构
[1] Ewha Womans Univ, Dept Obstet & Gynecol, Seoul 151070, South Korea
[2] Ewha Womans Univ, Med Res Ctr, Seoul, South Korea
[3] Ewha Womans Univ, Dept Prevent Med, Seoul, South Korea
[4] Ewha Womans Univ, Dept Physiol, Seoul, South Korea
[5] Chung Ang Univ, Dept Anim Sci & Technol, Coll Ind Sci, Gyungki Do, South Korea
关键词
preeclampsia; stress-related enzyme; CYP1A1; genotype; GSTT genotype; MPO genotype; MnSOD genotype;
D O I
10.1016/j.ejogrb.2004.06.009
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to determine whether genetic variability in oxidative stress-related enzymes contributes to individual preeclampsia susceptibility differences. Study Design: Polymorphisms in the cytochrome P450 (CYP)1A1 (Mspl), CKP1A1(Ile/Val), glutathione S-transferase (GS7-)M1, GSTT1, myeloperoxidase (MPO), and manganese superoxide dismutase (MnSOD) genes were evaluated by polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism (RFLP) in 214 healthy controls with an uncomplicated obstetric history, and in 121 preeclampsia patients. X analyses were used to statistically evaluate differences. Results: No significant differences in the CYP1A1(Mspl) or CYP1A1(Ile/Val) genotypes were observed between the healthy controls and the preeclampsia patients (X = 1.43, P = 0.49 versus X = 1.54, P = 0.46). The GSTM1 homozygous null type and GSTT1 homozygous null type were no differences in the patients and controls (X-2 = 0.01, P = 0.92 versus X-2 = 0.31, P = 0.57), and no significant differences in the polymorphisms of the MPO and MnSOD genotypes were found between the patients and controls (X-2 = 2.00, P = 0.37 versus X2 = 0.07, P = 0.96). Conclusion: Polymorphisms in the oxidative stress-related genes (CYP1A1, GSTM1, GSTT1, MPO, MnSOD) do not seem to be risk factors for preeclampsia. (c) 2004 Published by Elsevier Ireland Ltd.
引用
收藏
页码:42 / 46
页数:5
相关论文
共 24 条
[1]  
Ambrosone CB, 1999, CANCER RES, V59, P602
[2]  
ANDERSON KE, 1985, FED PROC, V44, P130
[3]   GLUTATHIONE S-TRANSFERASES - BIOMEDICAL APPLICATIONS [J].
BECKETT, GJ ;
HAYES, JD .
ADVANCES IN CLINICAL CHEMISTRY, VOL 30, 1993, 30 :281-380
[4]   GENETIC RISK AND CARCINOGEN EXPOSURE - A COMMON INHERITED DEFECT OF THE CARCINOGEN-METABOLISM GENE GLUTATHIONE-S-TRANSFERASE M1 (GSTM1) THAT INCREASES SUSCEPTIBILITY TO BLADDER-CANCER [J].
BELL, DA ;
TAYLOR, JA ;
PAULSON, DF ;
ROBERTSON, CN ;
MOHLER, JL ;
LUCIER, GW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (14) :1159-1164
[5]   Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs) [J].
Brockstedt, U ;
Krajinovic, M ;
Richer, C ;
Mathonnet, G ;
Sinnett, D ;
Pfau, W ;
Labuda, D .
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2002, 516 (1-2) :41-47
[6]  
DALY AK, 1995, J MOL MED-JMM, V73, P539
[7]   Etiology and pathogenesis of preeclampsia: Current concepts [J].
Dekker, GA ;
Sibai, BM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (05) :1359-1375
[8]  
Eaton DL, 2000, NEUROTOXICOLOGY, V21, P101
[9]   GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity [J].
Gronau, S ;
Koenig-Greger, D ;
Jerg, M ;
Riechelmann, H .
ORAL DISEASES, 2003, 9 (02) :62-67
[10]   GENETIC-LINKAGE OF LUNG CANCER-ASSOCIATED MSPI POLYMORPHISMS WITH AMINO-ACID REPLACEMENT IN THE HEME BINDING REGION OF THE HUMAN CYTOCHROME-P450IA1 GENE [J].
HAYASHI, S ;
WATANABE, J ;
NAKACHI, K ;
KAWAJIRI, K .
JOURNAL OF BIOCHEMISTRY, 1991, 110 (03) :407-411